Does a single bolus thrombolytic reduce door to needle time in a district general hospital?
OBJECTIVE
To answer the question "In patients presenting with ST elevation acute myocardial infarction (STEMI) and no contraindication to thrombolysis, does the introduction of Tenecteplase reduce door to needle times?"


METHODS
Firstly, an observational study was performed to compare the time taken to prepare standard thrombolytic therapy with Tenecteplase. Secondly, door to needle times were compared before and after the introduction of Tenecteplase. The study was powered to be 80% sure of finding a change of 10% in the number of patients meeting the national service framework standard of a 30 minute door to needle time.


RESULTS
Tenecteplase takes 10.5 minutes less time to prepare than standard treatment (p value <0.001). After the introduction of Tenecteplase the percentage of patients receiving thrombolysis in 30 minutes increased from 58% to 76% (p value <0.01)


CONCLUSIONS
Tenecteplase is quicker to prepare than standard therapy, resulting in a significant improvement in performance against the national service framework target.
Leah
V
V
Department of Emergency Medicine, Darent Valley Hospital, Dartford, Kent, UK. leah_vicki@hotmail.com <leah_vicki@hotmail.com>
Clark
C
C
Doyle
K
K
Coats
T J
TJ
D004630:Emergencies; D004636:Emergency Service, Hospital / Q000592:standards; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D000077785:Tenecteplase; D015912:Thrombolytic Therapy / Q000379:methods*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase